Endovascular Therapy for a Patient With Chronic Mesenteric Ischemia

Ke, Shin Rong; Chiang, Fu-Tien

doi:10.1016/s0929-6646(10)60058-7

Cited by 3 publications

(2 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Actualmente, existen múltiples estudios en los cuales se evalúan el tratamiento quirúrgico abierto y el endovascular 15,22,23,[27][28][29][30] . En un estudio en los Estados Unidos de 22.413 pacientes con isquemia mesentérica crónica sometidos a reperfusión, se encontró que con el tratamiento endovascular, la mediana de la estancia hospitalaria fue menor (5 Vs. 11 días; p<0,001) y, también, la morbilidad (20 Vs. 38 %; p<0,001); en el análisis multivariado, la mortalidad fue cinco veces mayor en el grupo de reperfusión abierta (odds ratio, OR=5,1) (IC 95% 3,1-8,4; p=0,001) (23).…”

Section: Discussionunclassified

Isquemia mesentérica crónica en una anciana con demencia: un reto diagnóstico

2017

View full text Add to dashboard Cite

Abdominal pain is a common cause of visit to the emergency room and the elderly population is prone to present this situation. In this group of patients the difficulty lies in its particular features, like multiple comorbidities and multiple medications, cognitive impairment and poorly informed caregivers, a situations that favors multiple consultations leading to inaccurate and delayed diagnoses. A cause of abdominal pain in the elderly includes vascular catastrophes, such as mesenteric angina, an infrequent disease associated high mortality because diagnosis and treatment are delayed by virtue of the atypical presentation in this population. We report the case of an elderly female with history of vascular dementia who consulted for chronic abdominal pain that was diagnosed as chronic mesenteric angina.

show abstract

Section: Discussionunclassified

Isquemia mesentérica crónica en una anciana con demencia: un reto diagnóstico

2017

View full text Add to dashboard Cite

show abstract

“…Mortality rates in several articles vary from 0-17% after endovascular therapy. [5][6][7] Morbidity rate ranges between 19-54% 4 (Table 3). A cumulative analysis of Kougias et al in 2007 8,9 showed technical success of endovascular treatment in 91% of the cases, with a complication rate of 9%, and a 30-day mortality of 3%.…”

Section: Discussionmentioning

confidence: 99%

Mid-Term Outcomes of Endovascular Treatment for Symptomatic Chronic Mesenteric Ischemia

Schönefeld

Szesny

Donas

et al. 2011

Surgical Techniques Development

View full text Add to dashboard Cite

The authors would present the mid-term outcomes with the use of stent-supported angioplasty in the treatment of symptomatic chronic mesenteric ischemia (CMI). The present study is a retrospective analysis of 36 patients undergoing endovascular treatment of symptomatic CMI, between November 2000 and September 2009. Primary study endpoints were defined as primary patency, periprocedural and midterm mortality and complications, and symptom improvement after intervention. Forty-one mesenteric arteries (77.3% stenotic and 22.7% occluded vessels) were treated in 36 patients with 42 stents. In 30 patients (83.3%) one visceral artery and in 6 cases (16.7%) two visceral arteries were treated. Overall mortality was 16.7% (n=6) after a 60-month follow-up (mean follow-up period 30.1 months). Two early (<30-day) deaths were caused by visceral ischemia (n=2: 5.5%). Late death was procedure-related in one patient with re-occlusion of the superior mesenteric artery after 12 months. The other 3 patients died from non procedure-related causes; e.g. twice myocardial infarction. Initial symptom relief was observed in 29 patients (80.5%); 7 patients reported no change. Primary patency was 83.3% after 5 years and secondary patency was 90.5% (38 out of 42 stents) among all patients. Two conversions to open surgery were documented. First-line endovascular approach of CMI is a reasonable strategy. Close follow-up is mandatory due to symptom recurrence and restenosis

show abstract

A Rare Case of Ischemia–Reperfusion Injury After Mesenteric Revascularization

Robles-Martín

Reyes-Ortega

Rodríguez-Morata

2019

Vasc Endovascular Surg

View full text Add to dashboard Cite

Endovascular treatment of chronic mesenteric ischemia is currently the treatment of choice, regardless of the number of involved vessels. Unlike other anatomic areas, the hyperperfusion produced by revascularization and the consecutive reperfusion syndrome is only described in cases of acute bowel ischemia, which is usually resolved with traditional surgery. We present a case of severe hyperperfusion syndrome secondary to endovascular correction with stents of a critical ischemia affecting the celiac trunk and superior mesenteric artery.

show abstract

Endovascular Therapy for a Patient With Chronic Mesenteric Ischemia

Cited by 3 publications

References 10 publications

Isquemia mesentérica crónica en una anciana con demencia: un reto diagnóstico

Isquemia mesentérica crónica en una anciana con demencia: un reto diagnóstico

Mid-Term Outcomes of Endovascular Treatment for Symptomatic Chronic Mesenteric Ischemia

A Rare Case of Ischemia–Reperfusion Injury After Mesenteric Revascularization

Contact Info

Product

Resources

About